Wall Street bounces back as investors shrug off trade tensions
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Nike (NKE) PT Raised to $100 at Susquehanna Ahead of 1Q Release
September 20, 2018 7:20 AM EDTSusquehanna analyst Sam Poser raised the price target on Nike (NYSE: NKE) to $100.00 (from $93.00) while maintaining a Positive rating ahead of the company's 1Q earnings report. Proprietary checks indicate that the momentum of Nike Sportswear (NSW) continues to accelerate. NSW footwear continues to... More
Marsh & McLennan (MMC) PT Lowered to $98 at Citi Following JLT Acquisition
September 20, 2018 7:14 AM EDTCiti analyst James Naklicki lowered the price target on Marsh & McLennan (NYSE: MMC) to $98.00 (from $100.00) while maintaining a Buy rating as the company acquires JLT. MMC is acquiring nearly $2 billion in revenue from the deal, which will increase the gap between MMC... More
Viking Therapeutic (VKTX) PT Raised to 'Street High' $28 at H.C. Wainwright
September 18, 2018 11:57 AM EDTH.C. Wainwright analyst Joseph Pantginis raised the price target on Viking Therapeutic (NASDAQ: VKTX) to a 'Street High' $28.00 (from $15.00) while maintaining a Buy rating.
The analsyt commented, "This morning, the highly anticipated VK2809 top-line data in non-alcoholic fatty liver disease (NAFLD) and... More

